Tibet Rhodiola Pharmaceutical Holding Co (600211) — Capital Reinvestment Ratio
Tibet Rhodiola Pharmaceutical Holding Co (600211) has a Capital Reinvestment Ratio of 0.02x as of December 2025, meaning it reinvests 0% of its operating cash flow (CN¥297.86 Million) in capital expenditures (CN¥4.98 Million). See Tibet Rhodiola Pharmaceutical Holding Co (600211) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Tibet Rhodiola Pharmaceutical Holding Co Capital Reinvestment Ratio (1999–2025)
This chart tracks Tibet Rhodiola Pharmaceutical Holding Co's Capital Reinvestment Ratio across 25 annual periods.
Annual Capital Reinvestment Ratio for Tibet Rhodiola Pharmaceutical Holding Co (1999–2025)
Year-by-year Capital Reinvestment Ratio for Tibet Rhodiola Pharmaceutical Holding Co from 1999 to 2025. For live market cap and broader valuation context, see Tibet Rhodiola Pharmaceutical Holding Co (600211) market capitalisation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.02x | CN¥1.03 Billion | CN¥15.96 Million | ▼ -58.9% |
| 2024 | 0.04x | CN¥994.79 Million | CN¥37.60 Million | ▲ +88.6% |
| 2023 | 0.02x | CN¥1.08 Billion | CN¥21.69 Million | ▼ -83.5% |
| 2022 | 0.12x | CN¥837.38 Million | CN¥101.96 Million | ▼ -89.5% |
| 2021 | 1.16x | CN¥366.53 Million | CN¥425.58 Million | ▲ +124.7% |
| 2020 | 0.52x | CN¥428.17 Million | CN¥221.29 Million | ▲ +416.4% |
| 2019 | 0.10x | CN¥489.59 Million | CN¥49.00 Million | ▲ +23.9% |
| 2018 | 0.08x | CN¥289.22 Million | CN¥23.37 Million | ▼ -98.8% |
| 2017 | 6.65x | CN¥91.46 Million | CN¥607.98 Million | ▲ +17152.2% |
| 2016 | 0.04x | CN¥250.21 Million | CN¥9.64 Million | ▼ -51.6% |
| 2015 | 0.08x | CN¥133.93 Million | CN¥10.66 Million | ▼ -34.8% |
| 2013 | 0.12x | CN¥279.22 Million | CN¥34.12 Million | ▲ +55.4% |
| 2012 | 0.08x | CN¥56.20 Million | CN¥4.42 Million | ▼ -58.9% |
| 2011 | 0.19x | CN¥12.09 Million | CN¥2.31 Million | ▼ -85.9% |
| 2010 | 1.36x | CN¥1.90 Million | CN¥2.58 Million | ▲ +555.4% |
| 2009 | 0.21x | CN¥17.88 Million | CN¥3.70 Million | ▼ -7.5% |
| 2008 | 0.22x | CN¥21.46 Million | CN¥4.80 Million | ▼ -52.7% |
| 2006 | 0.47x | CN¥33.63 Million | CN¥15.90 Million | ▲ +26.5% |
| 2005 | 0.37x | CN¥18.92 Million | CN¥7.07 Million | ▼ -42.4% |
| 2004 | 0.65x | CN¥26.90 Million | CN¥17.45 Million | ▲ +33.8% |
| 2003 | 0.48x | CN¥47.20 Million | CN¥22.88 Million | ▼ -84.4% |
| 2002 | 3.11x | CN¥32.85 Million | CN¥102.14 Million | ▼ -39.7% |
| 2001 | 5.15x | CN¥15.47 Million | CN¥79.72 Million | ▼ -10.6% |
| 2000 | 5.76x | CN¥20.55 Million | CN¥118.45 Million | ▼ -79.5% |
| 1999 | 28.15x | CN¥2.25 Million | CN¥63.25 Million | — |